{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:49:32Z","timestamp":1780976972979,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA043204"],"award-info":[{"award-number":["DA043204"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS076517"],"award-info":[{"award-number":["NS076517"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00213-021-05791-1","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:13:40Z","timestamp":1613607220000},"page":"1585-1592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Synergistic antihyperalgesic and antinociceptive effects of morphine and methyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (MP-III-024): a positive allosteric modulator at \u03b12GABAA and \u03b13GABAA receptors"],"prefix":"10.1007","volume":"238","author":[{"given":"Mohammad A.","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Keck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Poe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dishary","family":"Sharmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"issue":"2 Suppl","key":"5791_CR1","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","volume":"11","author":"R Benyamin","year":"2008","unstructured":"Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R (2008) Opioid complications and side effects. Pain Physic 11(2 Suppl):S105\u2013S120","journal-title":"Pain Physic"},{"key":"5791_CR2","doi-asserted-by":"publisher","first-page":"172996","DOI":"10.1016\/j.pbb.2020.172996","volume":"196","author":"A Biggerstaff","year":"2020","unstructured":"Biggerstaff A, Kivell B, Smith JL, Mian MY, Golani LK, Rashid F, Sharmin D, Knutson DE, Cerne R, Cook JM, Witkin JM (2020) The \u03b12,3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance development. Pharmacol Biochem Behav 196:172996","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"5791_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuroscience.2009.06.025","volume":"163","author":"O Chudomel","year":"2009","unstructured":"Chudomel O, Herman H, Nair K, Mosh\u00e9 SL, Galanopoulou AS (2009) Age- and gender-related differences in GABAA receptor-mediated postsynaptic currents in GABAergic neurons of the substantia nigra reticulata in the rat. Neuroscience 163(1):155\u2013167. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.06.025","journal-title":"Neuroscience"},{"issue":"4","key":"5791_CR4","first-page":"263","volume":"28","author":"M Davies","year":"2003","unstructured":"Davies M (2003) The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J Psychiat Neurosci : JPN 28(4):263\u2013274","journal-title":"J Psychiat Neurosci : JPN"},{"issue":"3","key":"5791_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bcp.2014.12.010","volume":"93","author":"AG de Lucas","year":"2015","unstructured":"de Lucas AG, Ahring PK, Larsen JS, Rivera-Arconada I, Lopez-Garcia JA, Mirza NR, Munro G (2015) GABAA \u03b15 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085. Biochem Pharmacol 93(3):370\u2013379. https:\/\/doi.org\/10.1016\/j.bcp.2014.12.010","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"5791_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.neuropharm.2010.11.026","volume":"60","author":"A Di Lio","year":"2011","unstructured":"Di Lio A, Benke D, Besson M, Desmeules J, Daali Y, Wang ZJ et al (2011) HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain. Neuropharmacology 60(4):626\u2013632","journal-title":"Neuropharmacology"},{"issue":"6","key":"5791_CR7","doi-asserted-by":"publisher","first-page":"e1147","DOI":"10.1038\/tp.2017.124","volume":"7","author":"A Egerton","year":"2017","unstructured":"Egerton A, Modinos G, Ferrera D, McGuire P (2017) Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis. Transl Psychiatry 7(6):e1147\u2013e1147","journal-title":"Transl Psychiatry"},{"issue":"2","key":"5791_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00213-008-1130-y","volume":"198","author":"BD Fischer","year":"2008","unstructured":"Fischer BD, Miller LL, Henry FE, Picker MJ, Dykstra LA (2008) Increased efficacy of \u03bc-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL\/6 mice: comparison with (\u2212)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959). Psychopharmacology 198(2):271\u2013278","journal-title":"Psychopharmacology"},{"key":"5791_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.neuropharm.2010.08.011","volume":"59","author":"BD Fischer","year":"2010","unstructured":"Fischer BD, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM Jr, Cook JM, Furtm\u00fcller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK (2010) Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure. Neuropharmacology 59:612\u2013618","journal-title":"Neuropharmacology"},{"issue":"2","key":"5791_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00213-010-2142-y","volume":"215","author":"BD Fischer","year":"2011","unstructured":"Fischer BD, Atack JR, Platt DM, Reynolds DS, Dawson GR, Rowlett JK (2011) Contribution of GABA(A) receptors containing \u03b13 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys. Psychopharmacology 215(2):311\u2013319. https:\/\/doi.org\/10.1007\/s00213-010-2142-y","journal-title":"Psychopharmacology"},{"key":"5791_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainresbull.2017.03.001","volume":"131","author":"BD Fischer","year":"2017","unstructured":"Fischer BD, Schlitt RJ, Hamade BZ, Rehman S, Ernst M, Poe MM, Li G, Kodali R, Arnold LA, Cook JM (2017) Pharmacological and antihyperalgesic properties of the novel \u03b12\/3 preferring GABAA receptor ligand MP-III-024. Brain Res Bull 131:62\u201369. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.03.001","journal-title":"Brain Res Bull"},{"issue":"2","key":"5791_CR12","first-page":"247","volume":"174","author":"PK Gessner","year":"1970","unstructured":"Gessner PK, Cabana BE (1970) A study of the interaction of the hypnotic effects and of the toxic effects of chloral hydrate and ethanol. J Pharmacol Exp Ther 174(2):247\u2013259","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"5791_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.mayocp.2015.04.010","volume":"90","author":"RN Jamison","year":"2015","unstructured":"Jamison RN, Mao J (2015) Opioid Analgesics. Mayo Clin Proc 90(7):957\u2013968. https:\/\/doi.org\/10.1016\/j.mayocp.2015.04.010","journal-title":"Mayo Clin Proc"},{"issue":"7176","key":"5791_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature06493","volume":"451","author":"J Knabl","year":"2008","unstructured":"Knabl J, Witschi R, H\u00f6sl K, Reinold H, Zeilhofer UB, Ahmadi S, Brockhaus J, Sergejeva M, Hess A, Brune K, Fritschy JM, Rudolph U, M\u00f6hler H, Zeilhofer HU (2008) Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 451(7176):330\u2013334","journal-title":"Nature"},{"issue":"3","key":"5791_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pain.2008.10.015","volume":"141","author":"J Knabl","year":"2009","unstructured":"Knabl J, Zeilhofer UB, Crestani F, Rudolph U, Zeilhofer HU (2009) Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice. Pain 141(3):233\u2013238","journal-title":"Pain"},{"issue":"4","key":"5791_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","volume":"89","author":"J Le Merrer","year":"2009","unstructured":"Le Merrer J, Becker JA, Befort K, Kieffer BL (2009) Reward processing by the opioid system in the brain. Physiol Rev 89(4):1379\u20131412. https:\/\/doi.org\/10.1152\/physrev.00005.2009","journal-title":"Physiol Rev"},{"issue":"6","key":"5791_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1021\/acschemneuro.6b00447","volume":"8","author":"LA Lewter","year":"2017","unstructured":"Lewter LA, Fisher JL, Siemian JN, Methuku KR, Poe MM, Cook JM, Li JX (2017) Antinociceptive effects of a novel \u03b12\/\u03b13-subtype selective GABAA receptor positive allosteric modulator. ACS Chem Neurosci 8(6):1305\u20131312","journal-title":"ACS Chem Neurosci"},{"key":"5791_CR18","doi-asserted-by":"publisher","unstructured":"Li C, Lei Y, Tian Y, Xu S, Shen X, Wu H, Bao S, Wang F (2019) The etiological contribution of GABAergic plasticity to the pathogenesis of neuropathic pain. Mol Pain 15:1744806919847366. https:\/\/doi.org\/10.1177\/1744806919847366","DOI":"10.1177\/1744806919847366"},{"key":"5791_CR19","volume-title":"Opioid Receptor Ligands, Burger's Medicinal Chemistry and Drug Discovery","author":"CR McCurdy","year":"2003","unstructured":"McCurdy CR, Prisinzano TE, Abraham DJ (2003) Opioid Receptor Ligands, Burger's Medicinal Chemistry and Drug Discovery. John Wiley & Sons, Inc, Hoboken"},{"issue":"3","key":"5791_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1124\/jpet.108.144568","volume":"327","author":"G Munro","year":"2008","unstructured":"Munro G, Lopez-Garcia JA, Rivera-Arconada I, Erichsen HK, Nielsen E\u00d8, Larsen JS, Mirza NR (2008) Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3\u2032-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 327(3):969\u2013981","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"5791_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/npp.2013.221","volume":"39","author":"J Paul","year":"2014","unstructured":"Paul J, Y\u00e9venes GE, Benke D, Di Lio A, Ralvenius WT, Witschi R, Scheurer L, Cook JM, Rudolph U, Fritschy JM, Zeilhofer HU (2014) Antihyperalgesia by \u03b12-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites. Neuropsychopharmacology 39(2):477\u2013487. https:\/\/doi.org\/10.1038\/npp.2013.221","journal-title":"Neuropsychopharmacology"},{"key":"5791_CR22","doi-asserted-by":"publisher","first-page":"10800","DOI":"10.1021\/acs.jmedchem.6b01332","volume":"59","author":"MM Poe","year":"2016","unstructured":"Poe MM, Methuku KR, Li G, Verma AR, Teske KA, Stafford DC, Arnold LA, Cramer JW, Jones TM, Cerne R, Krambis MJ, Witkin JM, Jambrina E, Rehman S, Ernst M, Cook JM, Schkeryantz JM (2016) Synthesis and Characterization of a Novel \u03b3-Aminobutyric Acid Type A (GABAA) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy. J Med Chem 59:10800\u201310806","journal-title":"J Med Chem"},{"key":"5791_CR23","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1038\/ncomms7803","volume":"6","author":"WT Ralvenius","year":"2015","unstructured":"Ralvenius WT, Benke D, Acu\u00f1a MA, Rudolph U, Zeilhofer HU (2015) Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype. Nat Commun 6:6803","journal-title":"Nat Commun"},{"issue":"9","key":"5791_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrd3502","volume":"10","author":"U Rudolph","year":"2011","unstructured":"Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABA A receptor subtypes. Nat Rev Drug Discov 10(9):685\u2013697","journal-title":"Nat Rev Drug Discov"},{"issue":"Pt B","key":"5791_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejphar.2015.05.012","volume":"763","author":"Y Shang","year":"2015","unstructured":"Shang Y, Filizola M (2015) Opioid receptors: Structural and mechanistic insights into pharmacology and signaling. Eur J Pharmacol 763(Pt B):206\u2013213. https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.012","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"5791_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/jpet.116.232421","volume":"357","author":"JN Siemian","year":"2016","unstructured":"Siemian JN, Obeng S, Zhang Y, Zhang Y, Li JX (2016) Antinociceptive interactions between the imidazoline I2 receptor agonist 2-BFI and opioids in rats: role of efficacy at the \u03bc-opioid receptor. J Pharmacol Exp Ther 357(3):509\u2013519","journal-title":"J Pharmacol Exp Ther"},{"key":"5791_CR27","doi-asserted-by":"publisher","DOI":"10.1201\/9781420036107","volume-title":"Drug Synergism and Dose-Effect Data Analysis","author":"RJ Tallarida","year":"2000","unstructured":"Tallarida RJ (2000) Drug Synergism and Dose-Effect Data Analysis. Chapman & Hall\/CRC Press, Boca Raton"},{"key":"5791_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","volume":"98","author":"RJ Tallarida","year":"2002","unstructured":"Tallarida RJ (2002) The interaction index: a measure of drug synergism. Pain 98:163\u2013168","journal-title":"Pain"},{"key":"5791_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pbb.2019.02.013","volume":"180","author":"JM Witkin","year":"2019","unstructured":"Witkin JM, Cerne R, Davis PG, Freeman KB, do Carmo JM, Rowlett JK, Methuku KR, Okun A, Gleason SD, Li X, Krambis MJ, Poe M, Li G, Schkeryantz JM, Jahan R, Yang L, Guo W, Golani LK, Anderson WH, Catlow JT, Jones TM, Porreca F, Smith JL, Knopp KL, Cook JM (2019) The \u03b12,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats. Pharmacol Biochem Behav 180:22\u201331","journal-title":"Pharmacol Biochem Behav"},{"issue":"22","key":"5791_CR30","doi-asserted-by":"publisher","first-page":"8134","DOI":"10.1523\/JNEUROSCI.6328-10.2011","volume":"31","author":"R Witschi","year":"2011","unstructured":"Witschi R, Punnakkal P, Paul J, Walczak JS, Cervero F, Fritschy JM, Kuner R, Keist R, Rudolph U, Zeilhofer HU (2011) Presynaptic alpha2-GABAA receptors in primary afferent depolarization and spinal pain control. J Neurosci Off J Soc Neurosci 31(22):8134\u20138142. https:\/\/doi.org\/10.1523\/JNEUROSCI.6328-10.2011","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"5791_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1152\/physrev.00043.2010","volume":"92","author":"HU Zeilhofer","year":"2012","unstructured":"Zeilhofer HU, Wildner H, Y\u00e9venes GE (2012) Fast synaptic inhibition in spinal sensory processing and pain control. Physiol Rev 92:193\u2013235","journal-title":"Physiol Rev"},{"issue":"10","key":"5791_CR32","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1111\/bph.13470","volume":"173","author":"Q Zhu","year":"2016","unstructured":"Zhu Q, Sun Y, Mao L, Liu C, Jiang B, Zhang W, Li JX (2016) Antinociceptive effects of sinomenine in a rat model of postoperative pain. Br J Pharmacol 173(10):1693\u20131702","journal-title":"Br J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05791-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05791-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05791-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T04:06:45Z","timestamp":1621570005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05791-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5791"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05791-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The corresponding author declares no conflict of interest<b>.<\/b>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}